Moreover, it was found that A2M has a moderate upregulation in almost all cancers except glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC), and stomach adenocarcinoma (STAD). Here, A2M is linked to head and neck squamous cell carcinoma.